CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Shares withheld for taxes | −8,274 | $1.92 | $16K | 17,066 |
| 2017-02-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise · Restricted Stock Unit | −25,340 | 79,654 | ||
| 2017-02-03 | Gross Jane A See Remarks | Option exercise | +18,135 | 21,793 | ||
| 2017-02-03 | Gross Jane A See Remarks | Shares withheld for taxes | −5,922 | $1.92 | $11K | 15,871 |
| 2017-02-03 | Gross Jane A See Remarks | Option exercise · Restricted Stock Unit | −18,135 | 117,608 | ||
| 2016-08-03 | White Marvin L President and CEO | Grant or award · Stock Option (right to buy) | +200,475 | 236,118 | ||
| 2016-08-03 | Stromatt Scott C Chief Medical Officer and SVP | Grant or award · Restricted Stock Unit | +54,762 | 54,762 | ||
| 2016-08-03 | Stromatt Scott C Chief Medical Officer and SVP | Grant or award · Restricted Stock Unit | +78,123 | 234,322 | ||
| 2016-08-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Grant or award · Restricted Stock Unit | +50,680 | 104,994 | ||
| 2016-08-03 | Stromatt Scott C Chief Medical Officer and SVP | Grant or award · Restricted Stock Unit | +54,762 | 54,762 | ||
| 2016-08-03 | Stromatt Scott C Chief Medical Officer and SVP | Grant or award · Restricted Stock Unit | +78,124 | 78,124 | ||
| 2016-08-03 | Niederhuber John Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2016-08-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Grant or award · Restricted Stock Unit | +50,680 | 50,680 | ||
| 2016-08-03 | Harsanyi Zsolt Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2016-08-03 | Abdun-Nabi Daniel Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2016-08-03 | El-Hibri Fuad Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2016-08-03 | Kunz Barbara Lopez Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2016-08-03 | Grant Grady III Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2016-08-03 | White Marvin L President and CEO | Grant or award · Stock Option (right to buy) | +200,475 | 200,475 | ||
| 2016-08-01 | Emergent BioSolutions Inc. 10% owner | Other disposition | −20,229,849 | 0 |
Page 26 of 27 · 523 trades